# 10E8.4/iMab Bispecific Antibody and VRC07-523LS Monoclonal Antibody in HIV-infected Adults

> **NCT05890963** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **David Ho** · enrollment: 20 (actual)

## Conditions studied

- HIV-1-infection

## Interventions

- **DRUG:** ART
- **DRUG:** 10E8.4/iMab
- **DRUG:** VRC07-523LS

## Key facts

- **NCT ID:** NCT05890963
- **Lead sponsor:** David Ho
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-11-28
- **Primary completion:** 2026-04-14
- **Final completion:** 2027-05
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-04-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05890963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05890963, "10E8.4/iMab Bispecific Antibody and VRC07-523LS Monoclonal Antibody in HIV-infected Adults". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05890963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*